AC
Aisling Capital Portfolio holdings
AUM
$45.3M
This Quarter Return
+8.62%
1 Year Return
-15.24%
3 Year Return
+386.13%
5 Year Return
+1,047.82%
10 Year Return
–
AUM
$66.5M
AUM Growth
+$66.5M
(-81%)
Cap. Flow
-$289M
Cap. Flow
% of AUM
-434.45%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
9
New
–
Increased
–
Reduced
–
Closed
4
Top Buys
No buys this quarter
Top Sells
| 1 |
LOXO
Loxo Oncology, Inc
LOXO
|
$286M |
| 2 |
VRAY
ViewRay, Inc.
VRAY
|
$2.21M |
| 3 |
CMRX
Chimerix, Inc.
CMRX
|
$1.22M |
| 4 |
PTX
Pernix Therapeutics Holdings, Inc.
PTX
|
$88K |
Sector Composition
| 1 | Healthcare | 33.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
AIMT
1
DELISTED
Aimmune Therapeutics, Inc.
AIMT
| $44.5M | 66.84% | 1,990,000 | – | – |
|
2
ADMA Biologics
ADMA
$4.12B
| $13.7M | 20.55% | 3,608,171 | – | – |
|
|
ASXC
3
DELISTED
Asensus Surgical, Inc.
ASXC
| $5.69M | 8.55% | 2,389,352 | – | – |
|
4
Cidara Therapeutics
CDTX
$1.66B
| $2.71M | 4.07% | 1,021,148 | – | – |
|
|
CMRX
5
DELISTED
Chimerix, Inc.
CMRX
| – | – | -472,943 | Closed | -$1.22M |
|
|
VRAY
6
DELISTED
ViewRay, Inc.
VRAY
| – | – | -363,640 | Closed | -$2.21M |
|
|
LOXO
7
DELISTED
Loxo Oncology, Inc
LOXO
| – | – | -2,038,920 | Closed | -$286M |
|
|
PTX
8
DELISTED
Pernix Therapeutics Holdings, Inc.
PTX
| – | – | -210,000 | Closed | -$88K |
|